首页> 外文期刊>Medicine. >Tuberculosis-associated hemophagocytic lymphohistiocytosis with initial presentation of fever of unknown origin in a general hospital: An analysis of 8 clinical cases
【24h】

Tuberculosis-associated hemophagocytic lymphohistiocytosis with initial presentation of fever of unknown origin in a general hospital: An analysis of 8 clinical cases

机译:一家综合医院的结核相关的吞噬性淋巴细胞组织细胞增生伴有不明原因发热的初步表现:8例临床病例分析

获取原文
           

摘要

The study aimed to investigate the clinical features and prognoses of patients with tuberculosis (TB) who had secondary hemophagocytic lymphohistiocytosis (HLH). Patients first presenting with fever of unknown origin, who were ultimately diagnosed with TB-associated secondary HLH, were assessed retrospectively. We summarized and analyzed clinical manifestations, laboratory examinations, diagnoses, treatments, and prognoses of patients using clinical data, outpatient follow-up, and telephone follow-up in combination with literature review. Among patients admitted to the hospital with fever of unknown origin in the past 10 years, 371 patients were diagnosed with TB. Among them, 8 cases were diagnosed as tuberculosis-associated HLH (TB-HLH). The proportion of females among TB-HLH patients was higher than the proportion of females among TB patients. Within the same time period, 227 cases met the diagnostic criteria for HLH, among which TB-HLH patients accounted for 3.52% of the cases. None of the 8 TB-HLH patients had underlying diseases, and a majority of them had short symptom durations, rapid progression, along with multisystem and multiorgan dysfunctions. Their clinical manifestations were inconsistent with the typical clinical manifestations and imaging results characteristic of TB. Compared with patients with TB in our hospital during the same period, the 8 TB-HLH patients had a higher proportion of blood-disseminated TB and tuberculous meningitis. Apart from this, the hematological damage in these patients was higher than the common clinical manifestations of TB, and they also had a high proportion of respiratory failure. All 8 TB-HLH patients received antitubercular therapy, and 6 of them were also treated for HLH. However, their morbidity and mortality were significantly higher than that for reported cases of TB-HLH cases, both domestically and abroad, which may be attributed to the fever of unknown origin. Patients with TB-HLH had poor prognoses and no specific clinical manifestations. Therefore, cases of atypical TB and severe TB should be carefully monitored to achieve early diagnosis and early intervention.
机译:该研究旨在调查患有继发性吞噬性淋巴细胞组织细胞增生症(HLH)的结核病(TB)患者的临床特征和预后。回顾性评估首次出现不明原因发烧的患者,这些患者最终被确诊为结核病相关的继发性HLH。我们总结并分析了临床表现,实验室检查,诊断,治疗和患者预后,结合临床资料,门诊随访和电话随访。在过去十年中,因不明原因入院的患者中,有371名被诊断患有结核病。其中,有8例被诊断为结核相关性HLH(TB-HLH)。 TB-HLH患者中女性比例高于TB患者中女性比例。在同一时期,有227例符合HLH诊断标准,其中TB-HLH患者占3.52%。 8例TB-HLH患者均无基础疾病,且大多数症状持续时间短,病情进展快,以及多系统和多器官功能障碍。其临床表现与结核病的典型临床表现和影像学结果特征不一致。与同期我院结核病患者相比,这8例TB-HLH患者的血液弥散性结核病和结核性脑膜炎比例更高。除此之外,这些患者的血液学损害高于结核病的常见临床表现,并且他们也有较高比例的呼吸衰竭。所有8例TB-HLH患者均接受了抗结核治疗,其中6例也接受了HLH治疗。然而,其发病率和死亡率显着高于国内外报道的TB-HLH病例的发病率和死亡率,这可能归因于来源不明的发烧。 TB-HLH患者预后较差,无特定临床表现。因此,应仔细监测非典型肺结核和重度结核病例,以实现早期诊断和早期干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号